| Bid Price | High Price | ||
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2017 | 1,462.50 | 1,483.00 | 1,457.50 | 1,474.00 | 6,466,859 |
| Sep 21, 2017 | 1,457.50 | 1,481.65 | 1,455.50 | 1,468.00 | 7,110,474 |
| Sep 20, 2017 | 1,450.00 | 1,464.00 | 1,444.50 | 1,454.00 | 8,171,525 |
| Sep 19, 2017 | 1,454.50 | 1,461.50 | 1,444.00 | 1,452.00 | 11,993,118 |
| Sep 18, 2017 | 1,458.50 | 1,463.50 | 1,451.25 | 1,457.00 | 5,937,008 |
| Company Name | GlaxoSmithKline | Epic | GSK |
|---|---|---|---|
| ISIN | GB0009252882 | Index | FTSE 100 |
| EMS | 1,500 | Prev Close | 1,474.00 |
| Shares in Issue (m) | 4,918.52 | Market Cap (£m) | 72,203.91 |
| PE Ratio | 78.09 | Div per Share (p) | 80.00 |
| Div Yield | 5.45 | Div Cover | 0.24 |
| EPS | 18.80 | EPS Growth (%) | -89.21 |
| PEG | -0.88 | DPS Growth (%) | 0.00 |
| ROCE | 4.84 | Net Gearing | 83.31 |
| Quick Ratio | 0.61 | Current Ratio | 0.88 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 21 Sep | Deutsche Bank | Hold | 1,474.00 | 1,610.00 | 1,610.00 | Retains |
| 21 Sep | JP Morgan Cazenove | Neutral | 1,474.00 | - | - | Reiterates |
| 20 Sep | Shore Capital | Hold | 1,474.00 | - | - | Retains |
| 20 Sep | Deutsche Bank | Hold | 1,474.00 | 1,610.00 | 1,610.00 | Retains |
| 19 Sep | Bryan Garnier | Neutral | 1,474.00 | 1,710.00 | 1,710.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 26 Jul 2017 | Sir Roy Anderson | Buy | 567 @ 1,599.00p | £9,066.33 |
| 26 Jul 2017 | Sir Philip Hampton | Buy | 2,736 @ 1,599.00p | £43,748.64 |
| 26 Jul 2017 | Urs Rohner | Buy | 567 @ 1,599.00p | £9,066.33 |
| 26 Jul 2017 | Manvinder Banga | Buy | 2,267 @ 1,599.00p | £36,249.33 |
| 26 Jul 2017 | Dr Vivienne Cox | Buy | 449 @ 1,599.00p | £7,179.51 |
